Willow Biosciences Inc. announced that the Board of Directors has appointed Dr. Peter Seufer-Wasserthal as Interim President and Chief Executive Officer, effective July 17, 2022, in connection with Trevor Peters' retirement as President and CEO. Mr. Peters will continue to be a Director of the Company. In addition to the above mentioned changes, Ms. Barbara Munroe, a Director of the Company, has been appointed as Lead Independent Director.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.105 CAD | 0.00% |
|
-16.00% | +5.00% |
1st Jan change | Capi. | |
---|---|---|
+5.00% | 9.8M | |
+8.54% | 100B | |
+11.97% | 43.89B | |
-11.76% | 33.24B | |
-12.20% | 16.08B | |
+4.00% | 14.68B | |
-1.90% | 12.87B | |
+178.17% | 10.55B | |
-54.74% | 9.12B | |
+5.54% | 8.83B |
- Stock Market
- Equities
- WLLW Stock
- News Willow Biosciences Inc.
- Willow Biosciences Inc. Appoints Dr. Peter Seufer-Wasserthal as Chief Executive Officer